千亿·国际(中国)唯一官方网站
Other Affiliated Sites
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
A-Share Information
H-Share Information
2022.10.01
千亿国际:关于变更H股募集资金使用用途的公告
2022.10.01
千亿国际:关于召开2022年第二次临时股东大会的通知公告
2022.09.30
ANNOUNCEMENT PROPOSED ISSUANCE OF CORPORATE BONDS AND CHANGE IN USE OF PROCEEDS
2022.09.28
Notification Letter
2022.09.28
Interim Report 2022
2022.08.30
千亿国际:独立董事关于控股股东及其他关联方占用公司资金、公司对外担保情况的专项说明和...
2022.08.30
千亿国际:半年度非经营性资金占用及其他关联资金往来情况汇总表
2022.08.30
千亿国际:2022年半年度报告摘要
2022.08.30
千亿国际:2022年半年度报告
2022.08.29
INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2022
第一页
上一页
23
24
25
26
27
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.